InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, announces the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California. The acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to significantly expand its scientific and commercial impact by combining its expertise in high-content imaging, cell painting, and phenotypic analysis with InSphero’s globally recognized 3D microtissue platforms, AkuraFlow ™ microphysiological systems, and translational in vitro technologies.
Read the full article: InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-Based Assay Capabilities //
Source: https://www.businesswire.com/news/home/20260520349567/en/InSphero-AG-Acquires-PhenoVista-Biosciences-Inc.-to-Expand-Advanced-3D-Cell-based-Assay-Capabilities